Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00084825 | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 | completed | Phase 2 | 23 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 26, 2012 | clinicaltrials |
| NCT00771966 | Radical Prostatectomy and Perioperative Fluid Therapy | completed | Phase 4 | 44 | Rigshospitalet, DenmarkOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00002511 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | completed | Phase 3 | 1,005 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00658229 | The Physical Exercise and Prostate Cancer Study(PEPC) | completed | Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Oct 15, 2012 | clinicaltrials |
| NCT00080678 | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases | completed | Phase 2 | 116 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 12, 2012 | clinicaltrials |
| NCT00293371 | Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 6 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00313534 | Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer | terminated | Phase 1 | 15 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00379119 | Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer | terminated | — | 20 | University of California, San FranciscoOTHER | 1 | Oct 11, 2012 | clinicaltrials |
| NCT00670527 | [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases(PROPET) | unknown | N/A | 205 | Odense University HospitalOTHER | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00327340 | Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC | completed | Phase 2 | 70 | Achieve Life SciencesINDUSTRY | 1 | Oct 5, 2012 | clinicaltrials |
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | completed | N/A | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00833248 | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | completed | Phase 3 | 246 | Ferring PharmaceuticalsINDUSTRY | 7 | Oct 4, 2012 | clinicaltrials |
| NCT00284752 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | completed | Phase 2 | 56 | Kaiser PermanenteOTHER | 1 | Oct 1, 2012 | clinicaltrials |
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | terminated | Phase 2 | 2 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 27, 2012 | clinicaltrials |
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | completed | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00014586 | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | terminated | Phase 3 | 110 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | completed | Phase 2 | 40 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00042731 | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | completed | N/A | 79 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00065208 | Reiki/Energy Healing in Prostate Cancer | completed | Phase 1 / Phase 2 | 79 | The Cleveland ClinicOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00066391 | Irinotecan and Cisplatin in Treating Patients With Locally Advanced or Metastatic Penile Cancer | completed | Phase 2 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00085228 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | completed | Phase 2 | 116 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00617617 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | completed | Phase 2 | 52 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Sep 24, 2012 | clinicaltrials |
| NCT01663415 | A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Astellas Pharma Global Development, Inc.INDUSTRY | 0 | Sep 17, 2012 | clinicaltrials |
| NCT00739791 | Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer | completed | N/A | 34 | University of California, San FranciscoOTHER | 0 | Sep 14, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00992615 | Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer | completed | N/A | — | Poitiers University HospitalOTHER | 1 | Aug 29, 2012 | clinicaltrials |
| NCT00041301 | Assessing Quality of Life of Patients With Prostate Cancer | completed | — | 625 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Aug 27, 2012 | clinicaltrials |
| NCT00081601 | Study of CEP-701 in Treatment of Prostate Cancer | completed | Phase 2 | 30 | CephalonINDUSTRY | 1 | Aug 24, 2012 | clinicaltrials |
| NCT00450970 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)(SPERA) | terminated | Phase 3 | 344 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00752739 | Selenium in Treating Patients With Prostate Cancer | completed | Phase 2 | 220 | University of ArizonaOTHER | 1 | Aug 15, 2012 | clinicaltrials |
| NCT00978718 | Selenium in Preventing Prostate Cancer | completed | Phase 3 | 700 | University of ArizonaOTHER | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00514072 | Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer | unknown | Phase 2 | 54 | Kael-GemVax Co., Ltd.INDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00003343 | Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | completed | Phase 3 | 525 | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00388804 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | terminated | Phase 3 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00676780 | Green Tea Extract and Prostate Cancer | completed | Phase 2 | 33 | Louisiana State University Health Sciences Center ShreveportOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT00147238 | A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast | terminated | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00038168 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | completed | Phase 1 / Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00507351 | Ambulatory Cancer Pain Management: A Feasibility Study | completed | — | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00512096 | Neoadjuvant Chemotherapy for Patients With Squamous Cell Carcinoma of the Penis | completed | Phase 2 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00836238 | Questionnaire and Fall Risk Assessment | completed | — | 34 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00790595 | Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy | completed | Phase 1 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00901420 | Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients | terminated | — | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00003084 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | completed | Phase 2 | 75 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00080808 | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | completed | Phase 2 | 111 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Oct 26, 2012source: clinicaltrials